Dymeka Harrison News Today

Los Angeles, CA (PRWEB) May 10, 2022 -- The Exceptional Women Awardees Foundation (EWA) announces that after an extensive search, Dymeka Harrison, Chief

Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., will retire at the end of the year, following the lead of CEO Alex Gorsky, who also departs soon. Emile Nuwaysir led Bayer's $1 billion bet on Parkinson's disease, and now he heads up gene therapy biotech Ensoma. Genentech's early cancer research leader Shiva Malek jumps to Novartis' NIBR oncology unit.